DAB2IP loss confers the resistance of prostate cancer to androgen deprivation therapy through activating STAT3 and inhibiting apoptosis
about
Block one, unleash a hundred. Mechanisms of DAB2IP inactivation in cancer.Low expression of DAB2IP predicts an unfavorable prognosis in human bladder carcinoma.Cripto Enhances Proliferation and Survival of Mesenchymal Stem Cells by Up-Regulating JAK2/STAT3 Pathway in a GRP78-Dependent Manner.The prostate response to prolactin modulation in adult castrated rats subjected to testosterone replacement.
P2860
DAB2IP loss confers the resistance of prostate cancer to androgen deprivation therapy through activating STAT3 and inhibiting apoptosis
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
DAB2IP loss confers the resist ...... STAT3 and inhibiting apoptosis
@ast
DAB2IP loss confers the resist ...... STAT3 and inhibiting apoptosis
@en
DAB2IP loss confers the resist ...... TAT3 and inhibiting apoptosis.
@nl
type
label
DAB2IP loss confers the resist ...... STAT3 and inhibiting apoptosis
@ast
DAB2IP loss confers the resist ...... STAT3 and inhibiting apoptosis
@en
DAB2IP loss confers the resist ...... TAT3 and inhibiting apoptosis.
@nl
prefLabel
DAB2IP loss confers the resist ...... STAT3 and inhibiting apoptosis
@ast
DAB2IP loss confers the resist ...... STAT3 and inhibiting apoptosis
@en
DAB2IP loss confers the resist ...... TAT3 and inhibiting apoptosis.
@nl
P2093
P2860
P356
P1476
DAB2IP loss confers the resist ...... STAT3 and inhibiting apoptosis
@en
P2093
P2860
P356
10.1038/CDDIS.2015.289
P577
2015-10-29T00:00:00Z